Ovarian Cancer (UICC Monograph Series .11) (Softcover reprint of the original 1st ed. 1968. 2012. xii, 268 S. XII,)

個数:

Ovarian Cancer (UICC Monograph Series .11) (Softcover reprint of the original 1st ed. 1968. 2012. xii, 268 S. XII,)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版
  • 言語 ENG
  • 商品コード 9783642877575

Full Description

The incidence of ovarian cancer has progressively increased during the past decade, and its mortality rate has followed a similar course. Conversely, in cancer of the uterine cervix, the mortality rate has diminished. Detection and early diag­ nosis have been the two responsible factors in achieving the decrease in the number of deaths occurring in cancer of the cervix. The revers‾ is true in cancer of the ovary: diagnosis as a rule is only established late, when dissemination has already occurred, thus making the control of the disease much more difficult. Clinical staging thus far has not been in use at many centers, and it therefore becomes very difficult to compare results of treatment since we do not know the exact anatomical extent of the disease. Histopathological classification in cancer of the ovary is still a very controversial subject and a uniform terminology is urgently required. Management of patients with cancer of the ovary varies widely from one institu­ tion to another. There is no agreement as to how to treat an ovarian neoplasm; by surgery alone, or, by using radiation and chemotherapy as a complement to the operative treatment. In an effort to shed more light on these items, the Patient Care Committee of the UIce held this symposium, which was unique in the broadness of its scope pertaining to every phase of ovarian cancer.

Contents

General Classification of Ovarian Tumours.- Malignant Ovarian Tumours of Mullerian Origin: Some Aspects.- Endometrioid Tumours of the Ovary.- Sex-cord Mesenchyme Tumours. Pathologic Classification and its Relation to Prognosis and Treatment.- Tumours of Germinal Origin.- Lipoidic Cell Tumours of the Ovary.- Metastatic Ovarian Tumours.- Ovarian Cancer: Immunological Aspects. Influence on Prognosis and Treatment.- Diagnosis of Ovarian Carcinoma by Cul-de-sac Aspiration.- Cancer Cells in the Blood: Incidence and Importance to Prognosis and Treatment.- Clinical Staging in Ovarian Carcinoma.- Surgical Management — Conservative Surgery. Indications According to the Type of the Tumour.- Intestinal Surgery for Advanced Cancer of the Ovary.- Seropapillary and Endometrioid Carcinoma of the Ovary: Survival Rate after Surgery and Radiotherapy.- Megavoltage Irradiation in the Management of Malignant Ovarian Turnouts.- Intraperitoneal Colloidal Radiogold 198Au Therapy in Ovarian Cancer.- Intracavitary Chemotherapy in Ovarian Carcinoma.- Chemotherapy in Ovarian Cancer.- Systemic Chemotherapy in the Treatment of Ovarian Cancer.- Total Treatment of Ovarian Cancer. Justification and Importance of the Combination of the Various Therapeutic Methods.- Proposals for the Standardization of the Combined Treatment of Ovarian Cancer.

最近チェックした商品